Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Benefit Will Raise Employers' Drug Cost Savings Expectations, Express Scripts Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Beneficiary cost-sharing and tight drug formularies under Medicare Rx benefit will "spill over" into PBMs' commercial business, Express Scripts CEO Toan says. The PBM expects Medicare benefit to be neutral to earnings, even if Democrats win back White House.

You may also be interested in...



Express Scripts/NACDS Drug Card Needs 250,000 Enrollees To Be Profitable

Express Scripts estimates it will offer 20%-25% discounts on retail scripts and deeper discounts for mail order. PBM's level of participation in the 2006 Medicare Rx benefit will depend on the success of the discount card.

US FDA Expands Drug Development Tool Qualification Program With ISTAND Pilot

ClinROs, artificial intelligence-based algorithms will be included in approval pathway. FDA is taking a crash course on new techniques for trial assessment thanks to COVID.

Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue

Former acting Commissioner Josh Sharfstein argues that while agency officials have done a commendable job in overall communication on COVID vaccine development, more information is needed on the clinical holds.

Topics

UsernamePublicRestriction

Register

ID020288

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel